Real-time enrollment status for this high grade gliomas clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 4:44 PM UTC
| NCT Number | NCT07439172 |
| Recruiting Status | Recruiting |
| Condition | High Grade Gliomas |
| Phase | PHASE2 |
| Target Enrollment | 70 participants |
| Active Locations | 1 sites in the US |
| Sponsor | The Cooper Health System |
| Last Updated on CT.gov | October 9, 2026 (3 days ago) |
As of October 12, 2026: Clinical trial NCT07439172 is currently recruiting participants. This phase2 study for high grade gliomas is actively seeking new participants at 1 location across the United States. The study is sponsored by The Cooper Health System. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07439172 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07439172 was last updated 3 days ago (October 9, 2026). HelloStudys verifies this status automatically.